Aborehab Nora M, Waly Nermien E
Department of Biochemistry, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA University), 6th October Giza 12611, Egypt.
Department of Physiology, Faculty of Medicine, Helwan University, Cairo, 11795, Egypt.
Toxicol Rep. 2019 May 21;6:457-464. doi: 10.1016/j.toxrep.2019.05.008. eCollection 2019.
In this study, we investigated possible hepato-protective effects of , , and Aflatoxin B1 (AFB-1) induced hepatocellular carcinoma rat model. Fifty-four male albino rats were randomly assigned to experimental groups. Alcoholic extracts of aforementioned herbs were administered orally for 28 days at different doses. IL-6, hs-CRP, MDA, SOD and NFE2L2 were determined using ELISA. Histopathological changes in treated groups were examined. Herbal treatment significantly reduced IL-6, hs-CRP, and MDA ( < 0.001) whereas it significantly increased SOD (p < 0.001). 600 and 1000 increased NFE2L2 level compared to 500 group ( value<0.01). Histopathological evaluation of treated groups showed different grades of healing of the liver. This study confirms a beneficial hepatoprotective effect for aforementioned herbal extracts orally administered in rat model of AFB1 induced HCC. This effect is putatively mediated via modulation of inflammatory cytokines as well as amelioration of oxidative stress.
在本研究中,我们调查了[此处草药名称缺失]以及黄曲霉毒素B1(AFB - 1)诱导的肝细胞癌大鼠模型中可能存在的肝脏保护作用。54只雄性白化大鼠被随机分配到实验组。上述草药的醇提取物以不同剂量口服给药28天。使用酶联免疫吸附测定法(ELISA)测定白细胞介素 - 6(IL - 6)、超敏C反应蛋白(hs - CRP)、丙二醛(MDA)、超氧化物歧化酶(SOD)和核因子E2相关因子2(NFE2L2)。检查了治疗组的组织病理学变化。草药治疗显著降低了IL - 6、hs - CRP和MDA(p < 0.001),而显著提高了SOD(p < 0.001)。与500组相比,600和1000组增加了NFE2L2水平(p值<0.01)。治疗组的组织病理学评估显示肝脏有不同程度的愈合。本研究证实了上述草药提取物经口服给药对AFB1诱导的肝癌大鼠模型具有有益的肝脏保护作用。这种作用可能是通过调节炎性细胞因子以及减轻氧化应激来介导的。